184 related articles for article (PubMed ID: 6211045)
21. [Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri].
Tsyrlina EV; Sofroniĭ DF; Dil'man VM; Bokhman IaV; Vishnevskiĭ AS
Vopr Onkol; 1989; 35(6):675-80. PubMed ID: 2750079
[TBL] [Abstract][Full Text] [Related]
22. [Estrogen and progesterone receptors in the assessment of endometrial carcinoma].
Gao YL
Zhonghua Fu Chan Ke Za Zhi; 1984 Oct; 19(4):232-5, 258. PubMed ID: 6536440
[No Abstract] [Full Text] [Related]
23. [Endometrial cancer and cytosol steroid receptors].
Sas M; Thurzó L; Falkay G
Orv Hetil; 1983 Apr; 124(17):987-90. PubMed ID: 6866503
[No Abstract] [Full Text] [Related]
24. [Steroid receptor levels in human breast carcinomas in relation to serum hormone levels in postmenopausal patients (author's transl)].
Reiner G; Bieglmayer C; Jakesz R; Kees A; Kolb R; Spona J
Wien Klin Wochenschr; 1981 May; 93(11):339-42. PubMed ID: 6791390
[TBL] [Abstract][Full Text] [Related]
25. Sex steroid receptors in gynecologic cancer.
Hoffman PG; Siiteri PK
Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
[TBL] [Abstract][Full Text] [Related]
26. Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma.
Lantta M; Kahanpää K; Kärkkäinen J; Lehtovirta P; Wahlström T; Widholm O
Gynecol Oncol; 1984 Jun; 18(2):233-9. PubMed ID: 6735266
[TBL] [Abstract][Full Text] [Related]
27. [Steroid hormone receptors in struma].
Stoss F; Spona J
Wien Klin Wochenschr; 1987 Jun; 99(13):460-1. PubMed ID: 3630175
[TBL] [Abstract][Full Text] [Related]
28. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
[TBL] [Abstract][Full Text] [Related]
29. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging].
Kamatsuki S
Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181
[No Abstract] [Full Text] [Related]
30. Estradiol and progesterone receptors in gynecologic sarcomas.
Lantta M; Kärkkäinen J; Wahlström T; Widholm O
Acta Obstet Gynecol Scand; 1984; 63(6):505-8. PubMed ID: 6507052
[TBL] [Abstract][Full Text] [Related]
31. Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate.
Kumar VL; Wadhwa SN; Kumar V; Farooq A
J Surg Oncol; 1990 Jun; 44(2):122-8. PubMed ID: 1693995
[TBL] [Abstract][Full Text] [Related]
32. [Estrogen and progesterone receptor systems of the endometrium in benign tumors of the uterus and ovary].
Fanchenko ND; Adamian LV; Minina LS; Khel'mund K
Akush Ginekol (Mosk); 1987 Jul; (7):26-8. PubMed ID: 3688324
[No Abstract] [Full Text] [Related]
33. Growth of cavernous hemangioma with puberty.
Baker ER; Manders E; Whitney CW
Clin Pediatr (Phila); 1985 Oct; 24(10):596-8. PubMed ID: 3928228
[TBL] [Abstract][Full Text] [Related]
34. Preliminary observations on alterations in prolactin, gonadotropins, E2-17B & progesterone in patients with breast cancer.
Dash RJ; Behera D; Khanchi RK; Singh K
Indian J Med Res; 1987 Dec; 86():749-54. PubMed ID: 3131240
[No Abstract] [Full Text] [Related]
35. [Steroïd receptors in cancer of uterine cervix].
Bolla M; Chedin M; Chambaz E; Racinet C; Martin PM
Bull Cancer; 1982; 69(4):384. PubMed ID: 6891275
[No Abstract] [Full Text] [Related]
36. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
[TBL] [Abstract][Full Text] [Related]
37. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
Fernández-Montolí ME; Díez-Gibert O; Samaniego JM; Balagueró L; Navarro MA
Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
[TBL] [Abstract][Full Text] [Related]
38. Implications of subcellular steroid binding sites in endometrial cancer, determined by an immunofluorescent steroid-antibody technique and biochemical assay.
Tamaya T; Kimura J; Tsurusaki T; Kato Y; Fujimoto J; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):113-8. PubMed ID: 6366089
[TBL] [Abstract][Full Text] [Related]
39. [The activity of endometrial sex hormone receptors during the menstrual cycle and in endometrial cancer (proceedings)].
Pollow K; Schmidt-Gollwitzer M; Boquoi E
Arch Gynakol; 1977 Jul; 224(1-4):291-2. PubMed ID: 579824
[No Abstract] [Full Text] [Related]
40. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
Bonte J
Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
